FDA Approves Zanvastro, the First Treatment for Rare Alexander Disease
The drug targets the root cause of a rare, often fatal brain disease, and it grew out of more than 30 years of lab work in Wisconsin.
United States · · 3 min read
The drug targets the root cause of a rare, often fatal brain disease, and it grew out of more than 30 years of lab work in Wisconsin.
United States · · 3 min read
Real stories, checked facts, zero doom. One short email each morning, free.